Results 201 to 210 of about 7,952,783 (243)

Drug targeting to specific vascular sites

Drug Discovery Today, 2002
The blood vessels of individual tissues are biochemically distinct, and pathological lesions put their own signature on the vasculature. In tumors, both blood and lymphatic vessels differ from normal vessels. New methods, such as in vivo screening of phage libraries, have provided peptides and antibodies that recognize these vascular signatures and can
openaire   +2 more sources

Targeting angiogenesis in oncology, ophthalmology and beyond

Nature reviews. Drug discovery, 2023
Yihai Cao, R. Langer, N. Ferrara
semanticscholar   +1 more source

Targeting VEGF-induced vascular permeability

Nature Cardiovascular Research, 2022
Mark Richards, Lena Claesson-Welsh
openaire   +2 more sources

Vascular Targeting Agents

2008
Michael R. Horsman, Dietmar W. Siemann
openaire   +2 more sources

Radiotheranostics in oncology: Making precision medicine possible

Ca-A Cancer Journal for Clinicians, 2023
Eric Aboagye
exaly  

Vascular Targeting

2002
Renata Pasqualini, Wadih Arap
openaire   +1 more source

Targeted medical therapies for vascular anomalies

Hematology
Abstract The last 2 decades of genetic discovery in the field of vascular anomalies have brought targeted medical therapies to the forefront of care patients with vascular anomalies and have broadened the role of hematologists/oncologists in this field.
openaire   +2 more sources

Targeting cancer metabolism in the era of precision oncology

Nature Reviews Drug Discovery, 2021
Zachary T Schug, Joseph M Salvino, Chi V Dang   +2 more
exaly  

Targeting inflammation in atherosclerosis — from experimental insights to the clinic

Nature Reviews Drug Discovery, 2021
Oliver Soehnlein, Peter Libby
exaly  

Vascular Access in Oncology Patients

Ca-A Cancer Journal for Clinicians, 2008
Maurizio A Gallieni, Mauro Pittiruti, Roberto Biffi   +2 more
exaly